Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 2/20 | 0.38 |
| ▸ | RARG | P13631 | 2/20 | 0.38 |
| ▸ | RARA | P10276 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.35 |
| ▸ | PDCD1 | Q15116 | 3/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18475 | 1.00 | ALDH1A1 (0.40) | ALDH1A1GAAMAPTNPSR1RARB | |
| SCHEMBL8612375 | 0.83 | ALDH1A1 (0.39) | ALDH1A1GAAMAPTNPSR1RARB | |
| SCHEMBL14377497 | 0.83 | ALDH1A1 (0.45) | ALDH1A1GAAMAPTNPSR1RARB | |
| SCHEMBL8610756 | 0.82 | ALDH1A1 (0.38) | ALDH1A1GAAMAPTNPSR1RARB | |
| SCHEMBL29120373 | 0.79 | — | — | |
| SCHEMBL1105235 | 0.78 | MAPT (0.41) | ALDH1A1GAAMAPTNPSR1RARB | |
| SCHEMBL9495399 | 0.75 | RARB (0.38) | ALDH1A1GAAMAPTNPSR1RARB | |
| SCHEMBL17706525 | 0.74 | ALDH1A1 (0.40) | ALDH1A1GAAMAPTNPSR1RARB | |
| SCHEMBL14284324 | 0.73 | ALDH1A1 (0.39) | ALDH1A1GAAMAPTNPSR1RARB | |
| SCHEMBL7526780 | 0.73 | RARB (0.41) | ALDH1A1GAAMAPTNPSR1RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2723712-B1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP ASSETS BV (NL) | 2016-11-30 | — | — | EP | claimed |
| US-20140323767-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP ASSETS B.V. (NL) | 2014-10-30 | — | — | US | claimed |
| EP-2723712-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP Assets B.V. (NL) | 2014-04-30 | — | — | EP | claimed |
| WO-2012175396-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP ASSETS B.V. (NL) | 2012-12-27 | — | — | WO | claimed |
| US-20240124380-A1 | MANUFACTURING OF ALLENE KETONES USING AN AMMONIUM (THIO)SULFATES OR HYDROGEN (THIO)SULFATES | DSM IP ASSETS B.V. (NL) | 2024-04-18 | — | — | US | disclosed |
| US-20240116842-A1 | MANUFACTURING OF ALLENE KETONES USING AN AMMONIUM (THIO)SULFATES OR HYDROGEN (THIO)SULFATES | DSM IP ASSETS B.V. (NL) | 2024-04-11 | — | — | US | disclosed |
| EP-4288403-A1 | MANUFACTURING OF ALLENE KETONES USING AN AMMONIUM (THIO)SULFATES OR HYDROGEN (THIO)SULFATES | DSM IP Assets B.V. (NL) | 2023-12-13 | — | — | EP | disclosed |
| EP-4288402-A1 | MANUFACTURING OF ALLENE KETONES USING AN AMMONIUM (THIO)SULFATES OR HYDROGEN (THIO)SULFATES | DSM IP Assets B.V. (NL) | 2023-12-13 | — | — | EP | disclosed |
| EP-3976569-B1 | SELECTIVE HYDROGENATION OF ALKYNOLS TO ALKENOLS IN THE PRESENCE OF A PHOSPHORUS COMPOUND | DSM IP ASSETS BV (NL) | 2023-11-08 | — | — | EP | disclosed |
| CN-114907200-A | Preparation of allene ketone using copper sulfate or hydrate thereof | 帝斯曼知识产权资产管理有限公司 | 2022-08-16 | — | — | CN | disclosed |
| CN-114907195-A | Using tertiary amines with SO 3 Preparation of unsaturated ketones | 帝斯曼知识产权资产管理有限公司 | 2022-08-16 | — | — | CN | disclosed |
| WO-2022167641-A1 | MANUFACTURING OF ALLENE KETONES USING AN AMMONIUM (THIO)SULFATES OR HYDROGEN (THIO)SULFATES | DSM IP ASSETS B.V. (NL) | 2022-08-11 | — | — | WO | disclosed |
| EP-2797883-A1 | CATALYTIC SYNTHESIS OF VITAMIN A INTERMEDIATE | Dsm Ip Assets B.V. (NL) | 2014-11-05 | — | — | EP | disclosed |
| US-20140323767-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP ASSETS B.V. (NL) | 2014-10-30 | — | — | US | disclosed |
| US-20140323767-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP ASSETS B.V. (NL) | 2014-10-30 | — | — | US | disclosed |
| US-20140323767-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP ASSETS B.V. (NL) | 2014-10-30 | — | — | US | disclosed |
| EP-2723712-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP Assets B.V. (NL) | 2014-04-30 | — | — | EP | disclosed |
| WO-2013098095-A1 | CATALYTIC SYNTHESIS OF VITAMIN A INTERMEDIATE | DSM IP ASSETS B.V. (NL) | 2013-07-04 | — | — | WO | disclosed |
| WO-2012175396-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP ASSETS B.V. (NL) | 2012-12-27 | — | — | WO | disclosed |
| WO-2012175396-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | DSM IP ASSETS B.V. (NL) | 2012-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323767-A1 | PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE | CYP8B1, COASY, CYP51A1 | ALDH1A1 1817/4885GAA 1917/4885MAPT 2607/4885 |
| US-20240124380-A1 | MANUFACTURING OF ALLENE KETONES USING AN AMMONIUM (THIO)SULFATES OR HYDROGEN (THIO)SULFATES | TST, STS, KAT5 | ALDH1A1 2461/4885GAA 2836/4885MAPT 2023/4885 |
| US-20240116842-A1 | MANUFACTURING OF ALLENE KETONES USING AN AMMONIUM (THIO)SULFATES OR HYDROGEN (THIO)SULFATES | TST, STS, KAT5 | ALDH1A1 2461/4885GAA 2836/4885MAPT 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.